Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketoprofen, Cyclobenzaprine, and Caffeine vs Cyclobenzaprine and Caffeine for Osteomuscular Pain
NCT02862977Phase 3Completed
- Sponsor
- EMS
- Start
- Nov 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketoprofen in Musculoskeletal pain, sponsored by EMS. Started Nov 2017; status: completed.
02
Drugs
ketoprofen
03
Conditions
Musculoskeletal pain
Beyond the preview
Go deeper on NCT02862977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02862977.